Intellia Therapeutics Overview
Intellia Therapeutics Target Price
Where could NTLA trade next? Consensus target price: $18.
Get informed when a big investor buys or sells
+ FollowShare Price
$11.74
Average Target Price
$17.50
49.1% upside
49.1% upside6 analysts in the last 4 months
High: $25 | Low: $9
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-09 | WedbushDavid Nierengarten | $13 | 10.7% upside |  |
| 2026-08-07 | Evercore ISI | $24 | 104.4% upside | |
| 2026-07-15 | Wolfe ResearchAndy Chen | $9 |  23.3% downside | |
| 2026-07-10 | Wedbush | $17 | 44.8% upside | |
| 2026-06-15 | New Street | $25 | 112.9% upside | |
| 2026-05-13 | Bernstein | $17 | 44.8% upside | |
| 2026-05-12 | Canaccord Genuity | $49 | 317.4% upside | |
| 2026-04-27 | Chardan Capital | $30 | 155.5% upside | |
| 2026-04-27 | Leerink Partners | $35 | 198.1% upside | |
| 2026-04-27 | Morgan Stanley | $15 | 27.8% upside | |
| 2026-04-27 | Robert W. BairdJack Allen | $13 | 10.7% upside | |
| 2026-01-28 | KeyBanc | $25 | 112.9% upside | |
| 2026-01-27 | Robert W. BairdJack Allen | $7 | 40.4% downside | |
| 2025-11-11 | Evercore ISI | $8 | 31.9% downside | |
| 2025-11-10 | Truist Financial | $14 | 19.3% upside | |
| 2025-11-07 | Oppenheimer | $27 | 130% upside | |
| 2025-10-30 | WedbushDavid Nierengarten | $9 | 23.3% downside | |
| 2025-10-30 | H.C. WainwrightMitchell Kapoor | $18 | 53.3% upside | |
| 2025-10-30 | Robert W. BairdJack Allen | $9 | 23.3% downside | |
| 2025-10-28 | JMP Securities | $29 | 147% upside | |
| 2025-10-28 | Bernstein | $14.5 | 23.5% upside | |
| 2025-10-28 | BarclaysGena Wang | $24 | 104.4% upside | |
| 2025-10-28 | Tudor PickeringWilliam Pickering | $14.5 | 23.5% upside | |
| 2025-10-28 | RBC CapitalLuca Issi | $14 | 19.3% upside | |
| 2025-10-27 | Chardan Capital | $48 | 308.9% upside | |
| 2025-10-27 | H.C. WainwrightMitchell Kapoor | $25 | 112.9% upside | |
| 2025-10-06 | JMP SecuritiesSilvan Tuerkcan | $33 | 181.1% upside | |
| 2025-08-13 | GuggenheimDebjit Chattopadhyay | $14 | 19.3% upside | |
| 2025-02-28 | Goldman Sachs | $9 | 23.3% downside | |
| 2025-02-28 | Barclays | $26 | 121.5% upside | |
| 2024-11-11 | OppenheimerJay Olson | $60 | 411.1% upside | |
| 2024-10-24 | Robert W. BairdJack Allen | $18 | 53.3% upside | |
| 2024-08-09 | RBC CapitalLuca Issi | $54 | 360% upside | |
| 2024-06-24 | Stifel NicolausDae Gon Ha | $80 | 581.4% upside | |
| 2024-06-24 | Robert W. BairdJack Allen | $24 | 104.4% upside | |
| 2024-05-10 | BMO CapitalKostas Biliouris | $70 | 496.3% upside | |
| 2023-02-01 | Cantor Fitzgerald | $67 | 470.7% upside | |
| 2023-01-04 | Wells Fargo | $120 | 922.1% upside | |
| 2022-12-06 | Credit Suisse | $88 | 649.6% upside | |
| 2022-12-02 | Leerink Partners | $86 | 632.5% upside | |
| 2022-11-15 | Chardan Capital | $129 | 998.8% upside | |
| 2022-08-05 | Leerink Partners | $152 | 1194.7% upside | |
| 2022-08-05 | Chardan Capital | $146 | 1143.6% upside | |
| 2022-06-16 | BMO CapitalKostas Biliouris | $54 | 360% upside | |
| 2022-05-09 | JMP Securities | $110 | 837% upside | |
| 2022-05-09 | Raymond JamesSteven Seedhouse | $105 | 794.4% upside | |
| 2022-05-06 | Credit Suisse | $98 | 734.8% upside | |
| 2022-02-24 | RBC CapitalLuca Issi | $150 | 1177.7% upside | |
| 2022-02-18 | William BlairRaju Prasad | $144 | 1126.6% upside | |
| 2022-02-15 | Truist FinancialJoon Lee | $160 | 1262.9% upside | |